文献速递脑血管病认知障碍与痴呆

他汀使用与痴呆老年人心脑血管住院风险不降低相关

Statin Use Is Not Associated With Reduced Cardio- and Cerebrovascular Hospitalizations in Older Adults With Dementia.
PubMed 文献 · Stroke · 2025-11-17

结果显示,在痴呆人群中他汀使用与住院风险增加相关(HR 1.06,95%CI 1.01-1.12),而无痴呆人群主要分析未见差异。

要点

  • 痴呆患者使用他汀与心脑血管住院风险增加相关,需谨慎权衡。
  • 中等及高强度他汀与痴呆患者住院风险增加相关。
  • 新处方他汀的痴呆患者住院风险显著升高,应加强监测。

核心结论

  • 在痴呆养老院居民中,他汀使用与心脑血管事件住院风险增加相关,提示需进一步研究并谨慎考虑他汀使用。

主要发现

  • 痴呆患者中,他汀使用与心脑血管住院风险增加相关(HR 1.06,95%CI 1.01-1.12;P=0.023)。
  • 痴呆患者中,中等强度他汀(HR 1.15,95%CI 1.07-1.23;P<0.001)和高强度他汀(HR 1.55,95%CI 1.15-2.10;P=0.005)与住院风险增加相关。
  • 无痴呆人群主要分析未见差异(HR 1.03,95%CI 0.96-1.11;P=0.397),但高强度他汀组(HR 1.51,95%CI 1.04-2.19;P=0.029)和新处方他汀者(HR 1.99,95%CI 1.56-2.52)风险增加。

关键数值与推荐

  • 痴呆患者亚组:无动脉粥样硬化性心血管疾病者HR 1.30(95%CI 1.12-1.52;P<0.001)。
  • 痴呆患者亚组:血管性痴呆HR 1.18(95%CI 1.06-1.32;P=0.003),阿尔茨海默病HR 1.14(95%CI 1.00-1.31;P=0.047)。
  • 痴呆患者亚组:新处方他汀者HR 2.71(95%CI 2.33-3.15;P<0.001)。

临床怎么用

  • 对痴呆老年人处方他汀时应个体化评估获益与风险,尤其关注新处方及中高强度他汀者。
  • 用药期间需加强心脑血管事件监测,及时调整治疗方案。

局限性

  • 回顾性队列设计可能存在残余混杂。
  • 基于保险理赔数据,临床细节和用药依从性信息有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular and cerebrovascular diseases are significant global health challenges and leading causes of death worldwide. Although there is substantial evidence supporting the positive effects of statins for both primary and secondary prevention of these diseases, evidence is lacking regarding the benefits in people with dementia. This study investigated the associations between statin use and cardiovascular and cerebrovascular hospitalizations in nursing home residents with and without dementia. METHODS: This retrospective cohort study of nursing home residents with and without dementia using insurance claims data was conducted in Germany between January 2015 and December 2019. Propensity score-based models were used to evaluate the association of statin use with hospitalizations due to cerebrovascular and cardiovascular events among nursing home residents with and without dementia. Subgroup analyses were performed based on the presence or absence of atherosclerotic cardiovascular disease, dementia type, presence of hyperlipidemia, and newly prescribed statin use, as well as age groups, care dependency level, and sex. RESULTS: The final sample included data from 96 162 individuals, 37 262 without dementia, and 58 900 with dementia. Statin use was associated with an increased risk of hospitalization due to cardiovascular or cerebrovascular events among people with dementia (hazard ratio [HR], 1.06 [95% CI, 1.01-1.12]; P=0.023). Moderate and high statin intensity was associated with an increased risk of hospitalization (moderate: HR, 1.15 [95% CI, 1.07-1.23]; P<0.001; high: HR, 1.55 [95% CI, 1.15-2.10]; P=0.005) In subgroup analyses, we found an association between statin use and increased risk of hospitalization among individuals without atherosclerotic cardiovascular disease (HR, 1.30 [95% CI, 1.12-1.52]; P<0.001), with vascular dementia and Alzheimer disease (HR, 1.18 [95% CI, 1.06-1.32]; P=0.003; HR, 1.14 [95% CI, 1.00-1.31]; P=0.047, respectively) as well as among newly prescribed statin users (HR, 2.71 [95% CI, 2.33-3.15]; P<0.001). Among individuals without dementia, we found no differences (HR, 1.03 [95% CI, 0.96-1.11]; P=0.397) in the primary analysis and subanalyses except for the high statin intensity group (HR, 1.51 [95% CI, 1.04-2.19]; P=0.029) and among participants with newly prescribed statins (HR, 1.99 [95% CI, 1.56-2.52]). CONCLUSIONS: In our study, statin use was associated with an increased risk of hospitalization due to cardiovascular or cerebrovascular events among people with dementia. These findings highlight the need for further research and cautious consideration of statin use in people with dementia.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Lech S, Kohl R, O'Sullivan JL, et al. Statin Use Is Not Associated With Reduced Cardio- and Cerebrovascular Hospitalizations in Older Adults With Dementia. Stroke. 2025. PMID: 41243816. doi:10.1161/STROKEAHA.125.051157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。